Amedica, a commercial biomaterial company, is expected to report fourth quarter earnings on March 3, 2016.
Here are five highlights:
1. Analysts expect the company to report revenue of $4.78 million for the quarter.
2. Amedica is expected to report earnings per share of $0.05.
3. During the last three quarters, Amedica has registered negative earnings with an average miss of 58.67 percent.
4. In the third quarter, Amedica reported earnings per share of $0.15.
5. Revenue for the third quarter reached $4.8 million.
More articles on devices:
MidCap Business Credit becomes SpineFrontier's lending partner — 3 quick notes
OrthAlign to launch OrthAlign Plus for direct anterior hip replacement — 4 things to know
Burton's new Outpatient LED Examination Light has arrived